Our gross margins for the quarter were 8.4% and non-GAAP earnings per share were $0.22.
Non-GAAP earnings per share was $0.22 for the quarter and ROIC was 7.1%.
Our GAAP earnings per share for the quarter was $0.10 and our GAAP results included $2.9 million of restructuring and other non-recurring costs in Q1.
Even considering the challenging environment, we achieved revenue of $515 million in the first quarter, which were supported by strong demand in our Semi-Cap, Medical, and A&D sectors.
Because of the uncertain conditions related to COVID-19 we will not provide our usual detailed level next quarter guidance.
